• OUTLOOK ARENA
  • VIEWS ON NEWS
  • OCTOBER 31, 2000

P&G: Foussed approach paying off

P&G Health & Hygiene, the 51% Indian arm of global FMCG major Procter & Gamble, has made a terrific start in its first quarter of FY01. Though the turnover was stagnant in value terms, the company's expenditure took a 3% drop. As a result, P&G's operating margins improved to 23.4%.

(Rs m)1QFY001QFY01ChangeFY00
Sales1,1931,2010.7%4,751
Other Income214683.3%52
Expenditure949920-3.0%175
Operating Profit (EBDIT)24428115.0%4,576
Operating Profit Margin (%)20.5%23.4% 96.3%
Interest 111-87.6%2
Depreciation587326.7%10
Profit before Tax17722124.5%74
Tax283527.4%9
Profit after Tax/(Loss)15018524.0%65
Net profit margin (%)12.5%15.4% 1.4%
No. of Shares (eoy) (m)21.621.6 21.6
Earnings per share*27.634.3 3.0
*(annualised)    
Current P/e ratio 15.9  

The sales turnover though, is not comparable, as P&G discontinued shampoo manufacturing for its parent's 100% subsidiary P&G Home Products. If the impact of the shampoo manufacture revenues is removed, the sales growth amounts to around 14%.

A surge in its other income, coupled with a huge decline in its interest outgo helped P&G improve its 1QFY01 bottomline by 24% compared to the corresponding quarter in FY00.

P&G India has consciously focussed on becoming a two product company viz., Sanitary Napkins (Whisper) and anti-cold (Vicks). The company's products enjoy immense brand value. Unlike compatriot Hindustan Lever, P&G's strategy has revolved around premium positioning of both its product categories. In a sense, the company has been focussing on margins (value) rather than volumes.

The stock trades at Rs 547, a P/e multiple of 15.9 times its annualised FY01 expected earnings. The stock used to trade at a P/e ratio of 25-30 times, before the tech boom came.

Given the company's clear strategy on focusing on two products, as also its premium positioning, the company is better placed than most FMCG's to clock double digit growth figures both in its topline and bottomline in the medium term. In the long term however, P&G's two prduct focus might become a bane as competition picks up. There are also concerns regarding its parent's two 100% subsidiaries in India.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407